Design and Synthesis of S ‐Acetophenylhydrazones of 5‐Methyl‐1,3,4‐Thiadiazole‐2‐Thiol as SHP2 Inhibitory Agents
Chemistry & Biodiversity · 2025-09 · 22 (9)
DOI: 10.1002/cbdv.202402997 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 14.05.2025. Verfasst von Rangan Mitra und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Chemistry Research Laboratory II, Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hin…. Hauptthemen laut MEDLINE: Protein Tyrosine Phosphatase, Non-Receptor Type 11, Thiadiazoles, Drug Design, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben.
Abstract (Originalsprache)
We report herein the rational design, synthesis and evaluation of a library of 21 S ‐acetophenylhydrazones of 5‐methyl‐1,3,4‐thiadiazole‐2‐thiol bearing a substituted benzylidene moiety (compounds 5a – 5u ). Compound 5f (( E )‐ N '‐(2,6‐dichlorobenzylidene)‐2‐((5‐methyl‐1,3,4‐thiadiazol‐2‐yl)thio)acetohydrazide) emerged as the most potent SHP2 inhibitor (IC 50 = 0.120 ± 0.006 µM). Further, cell‐based studies revealed its moderate yet best‐in‐library cytotoxicity against MCF‐7 cells (IC 50 = 86.46 ± 2.32 µM) in a dose‐dependent manner. Compound 5f also exhibited in vitro anti‐survival (33% colony formation) and anti‐migratory effect (45% wound closure) on MCF‐7 cells upon treatment with sub‐IC 50 dose. In vivo toxicological evaluation of compound 5f revealed excellent safety profile in mice at an oral dose of 2000 mg/kg BW. Our current study yielded a novel heterocyclic scaffold designed through systematic lead‐guided optimization displaying submicromolar SHP2 inhibitory activity. The lead molecule identified from in vitro studies was effective against the proliferation, survival and migration of human breast cancer cells with an excellent in vivo safety profile.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaceutical Chemistry Research Laboratory II, Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi, Uttar Pradesh, India.
- Nanomedicine Research Laboratory, Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi, Uttar Pradesh, India.
- Pharmacology Research Laboratory, Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi, Uttar Pradesh, India.
ORCID-Profile: Rangan Mitra, Sandeep Kumar, Aiswarya Chaudhuri, Shreyasi Majumdar, Sairam Krishnamurthy, Ashish Kumar Agrawal, Senthil Raja Ayyannan
Zitieren
APA
Mitra, R., Kumar, S., Chaudhuri, A., Majumdar, S., Krishnamurthy, S., Agrawal, A. K., & Ayyannan, S. R. (2025). Design and Synthesis of S ‐Acetophenylhydrazones of 5‐Methyl‐1,3,4‐Thiadiazole‐2‐Thiol as SHP2 Inhibitory Agents. Chemistry & Biodiversity, 22(9). https://doi.org/10.1002/cbdv.202402997
Vancouver
Mitra R, Kumar S, Chaudhuri A, Majumdar S, Krishnamurthy S, Agrawal AK, et al. Design and Synthesis of S ‐Acetophenylhydrazones of 5‐Methyl‐1,3,4‐Thiadiazole‐2‐Thiol as SHP2 Inhibitory Agents. Chemistry & Biodiversity. 2025;22(9). doi:10.1002/cbdv.202402997
BibTeX
@article{Mitra2025,
author = {Mitra, Rangan and Kumar, Sandeep and Chaudhuri, Aiswarya and Majumdar, Shreyasi and Krishnamurthy, Sairam and Agrawal, Ashish Kumar and Ayyannan, Senthil Raja},
title = {Design and Synthesis of S ‐Acetophenylhydrazones of 5‐Methyl‐1,3,4‐Thiadiazole‐2‐Thiol as SHP2 Inhibitory Agents},
journal = {Chemistry & Biodiversity},
year = {2025},
volume = {22},
number = {9},
doi = {10.1002/cbdv.202402997}
}
EUVIMED